Many solid tumor cancers continue to be deadly diseases with few effective treatment options. Vesselon’s mission is to save lives and to improve quality of life with therapeutic agents that are protected in circulation and whose effects are amplified directly into tumors. We have a proprietary platform consisting of certain therapeutic agents in combination with our approved lipid microsphere drug to make the combination work significantly better across a spectrum of cancers and other serious disease targets (e.g., genetic diseases).